Company’s 36-month beta value is 0.71.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.” The public float for PSTV is ...

AUSTIN, Texas, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing ...

ProPhase Labs, Inc. (PRPH) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.30 per share a year ago. These figures ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Tesla, seen as a key beneficiary of the so-called 'Trump Trade' thanks in part to CEO Elon Musk, is set to open at the highest levels in more than a year.

As of 10:02 AM EST. Market Open.

SEC Filings provided by EDGAR Online, Inc.